Submitting OIG:
Report Description:
Payments made to providers for specimen validity tests did not comply with Medicare billing requirements. Specifically, Medicare improperly paid 4,480 clinical laboratories and physician offices a total of $66.3 million for specimen validity tests billed in combination with urine drug tests. Centers for Medicare & Medicaid Services (CMS) officials explained that medically necessary tests used to diagnose certain conditions (which include the same tests that can be used to validate urine specimens) that are performed on the same day as a urine drug test for a single beneficiary should be a rare occurrence.
Date Issued:
Wednesday, February 14, 2018
Agency Reviewed / Investigated:
Submitting OIG-Specific Report Number:
A-09-16-02034
Component, if applicable:
Centers for Medicare & Medicaid Services
Location(s):
Agency-Wide
Type of Report:
Audit
Questioned Costs:
$66,309,751
Funds for Better Use:
$12,146,760
Number of Recommendations:
2
View Document:
Attachment | Size |
---|---|
91602034.pdf | 896.24 KB |
Additional Details Link: